相似文献
1
NAFLD: Is There Anything New under the Sun?
Int J Mol Sci. 2017 Sep 12;18(9):1955. doi: 10.3390/ijms18091955.
2
Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.
Indian J Med Res. 2019 Jan;149(1):9-17. doi: 10.4103/ijmr.IJMR_1456_17.
3
Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
World J Gastroenterol. 2015 Apr 14;21(14):4103-10. doi: 10.3748/wjg.v21.i14.4103.
4
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology.
Atherosclerosis. 2014 Jan;232(1):99-109. doi: 10.1016/j.atherosclerosis.2013.10.030. Epub 2013 Nov 6.
5
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
World J Gastroenterol. 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539.
6
Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis.
Metabolomics. 2021 Jan 16;17(2):12. doi: 10.1007/s11306-020-01756-1.
7
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease.
World J Gastroenterol. 2016 Oct 7;22(37):8294-8303. doi: 10.3748/wjg.v22.i37.8294.
8
Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies.
Clin J Gastroenterol. 2015 Feb;8(1):1-9. doi: 10.1007/s12328-014-0548-5. Epub 2015 Jan 10.
9
Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.
Dig Dis Sci. 2015 Oct;60(10):3142-8. doi: 10.1007/s10620-015-3821-7. Epub 2015 Aug 7.
10
[Non-alcoholic fatty liver disease; a full-bodied epidemic].
Ned Tijdschr Geneeskd. 2020 Feb 27;164:D4096.
引用本文的文献
1
Optimum non-invasive predictive indicators for metabolic dysfunction-associated fatty liver disease and its subgroups in the Chinese population: A retrospective case-control study.
Front Endocrinol (Lausanne). 2022 Dec 1;13:1035418. doi: 10.3389/fendo.2022.1035418. eCollection 2022.
2
SHBG as a Marker of NAFLD and Metabolic Impairments in Women Referred for Oligomenorrhea and/or Hirsutism and in Women With Sexual Dysfunction.
Front Endocrinol (Lausanne). 2021 Mar 29;12:641446. doi: 10.3389/fendo.2021.641446. eCollection 2021.
3
Predicting Nonalcoholic Fatty Liver Disease through a Panel of Plasma Biomarkers and MicroRNAs in Female West Virginia Population.
Int J Mol Sci. 2020 Sep 13;21(18):6698. doi: 10.3390/ijms21186698.
4
Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLD.
Int J Environ Res Public Health. 2019 Sep 24;16(19):3570. doi: 10.3390/ijerph16193570.
5
Non-alcoholic fatty liver disease: a pandemic disease with multisystem burden.
Hepatobiliary Surg Nutr. 2018 Oct;7(5):389-391. doi: 10.21037/hbsn.2018.07.01.
6
Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver disease.
Clin Mol Hepatol. 2018 Sep;24(3):331-338. doi: 10.3350/cmh.2018.0006. Epub 2018 Jun 12.
本文引用的文献
1
The Telomeric Complex and Metabolic Disease.
Genes (Basel). 2017 Jul 7;8(7):176. doi: 10.3390/genes8070176.
2
Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.
Gut. 2017 Jun;66(6):1138-1153. doi: 10.1136/gutjnl-2017-313884. Epub 2017 Mar 17.
3
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis.
World J Gastroenterol. 2017 Feb 28;23(8):1458-1468. doi: 10.3748/wjg.v23.i8.1458.
4
Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease.
Nat Rev Nephrol. 2017 May;13(5):297-310. doi: 10.1038/nrneph.2017.16. Epub 2017 Feb 20.
5
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions.
Dig Liver Dis. 2017 May;49(5):471-483. doi: 10.1016/j.dld.2017.01.147. Epub 2017 Jan 23.
6
"Not all forms of NAFLD were created equal". Do metabolic syndrome-related NAFLD and PNPLA3-related NAFLD exert a variable impact on the risk of early carotid atherosclerosis?
Atherosclerosis. 2017 Feb;257:253-255. doi: 10.1016/j.atherosclerosis.2017.01.008. Epub 2017 Jan 18.
7
Molecular Pathogenesis of NASH.
Int J Mol Sci. 2016 Sep 20;17(9):1575. doi: 10.3390/ijms17091575.
8
Correlations of Hepatic Hemodynamics, Liver Function, and Fibrosis Markers in Nonalcoholic Fatty Liver Disease: Comparison with Chronic Hepatitis Related to Hepatitis C Virus.
Int J Mol Sci. 2016 Sep 14;17(9):1545. doi: 10.3390/ijms17091545.
9
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe.
Hepatology. 2016 Nov;64(5):1577-1586. doi: 10.1002/hep.28785. Epub 2016 Sep 26.
10
Aneuploidy and asynchronous replication in non-alcholic fatty liver disease and cryptogenic cirrhosis.
Gene. 2016 Nov 15;593(1):162-166. doi: 10.1016/j.gene.2016.08.017. Epub 2016 Aug 9.
Zotero 插件
